
PMID- 35196497
OWN - NLM
STAT- MEDLINE
DCOM- 20220316
LR  - 20220317
IS  - 2211-1247 (Electronic)
VI  - 38
IP  - 8
DP  - 2022 Feb 22
TI  - SENP2 suppresses browning of white adipose tissues by de-conjugating SUMO from
      C/EBPbeta.
PG  - 110408
LID - S2211-1247(22)00132-2 [pii]
LID - 10.1016/j.celrep.2022.110408 [doi]
AB  - The adipose tissue is a key site regulating energy metabolism. One of the
      contributing factors behind this is browning of white adipose tissue (WAT).
      However, knowledge of the intracellular determinants of the browning process
      remains incomplete. By generating adipocyte-specific Senp2 knockout (Senp2-aKO)
      mice, here we show that SENP2 negatively regulates browning by de-conjugating
      small ubiquitin-like modifiers from C/EBPbeta. Senp2-aKO mice are resistant to
      diet-induced obesity due to increased energy expenditure and heat production.
      Senp2 knockout promotes beige adipocyte accumulation in inguinal WAT by
      upregulation of thermogenic gene expression. In addition, SENP2 knockdown
      promotes thermogenic adipocyte differentiation of precursor cells isolated from
      inguinal and epididymal WATs. Mechanistically, sumoylated C/EBPbeta, a target of
      SENP2, suppresses expression of HOXC10, a browning inhibitor, by recruiting a
      transcriptional repressor DAXX. These findings indicate that a
      SENP2-C/EBPbeta-HOXC10 axis operates for the control of beige adipogenesis in
      inguinal WAT.
CI  - Copyright (c) 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
FAU - Lee, Ji Seon
AU  - Lee JS
AD  - Department of Biomedical Sciences, Seoul National University College of Medicine,
      Seoul, Korea.
FAU - Chae, Sehyun
AU  - Chae S
AD  - Neurovascular Unit Research Group, Korea Brain Research Institute, Daegu, Korea.
FAU - Nan, Jinyan
AU  - Nan J
AD  - Department of Biomedical Sciences, Seoul National University College of Medicine,
      Seoul, Korea.
FAU - Koo, Young Do
AU  - Koo YD
AD  - Department of Biomedical Sciences, Seoul National University College of Medicine,
      Seoul, Korea.
FAU - Lee, Seung-Ah
AU  - Lee SA
AD  - Genomic Medicine Institute, Medical Research Center, Seoul National University
      College of Medicine, Seoul, Korea.
FAU - Park, Young Joo
AU  - Park YJ
AD  - Department of Internal Medicine, Seoul National University College of Medicine,
      Seoul, Korea; Department of Molecular Medicine and Biopharmaceutical Sciences,
      Graduate School of Convergence Science and Technology, College of Medicine, Seoul
      National University, Seoul, Korea.
FAU - Hwang, Daehee
AU  - Hwang D
AD  - School of Biological Sciences, Seoul National University, Seoul, Korea.
FAU - Han, Weiping
AU  - Han W
AD  - Institute of Molecular and Cell Biology, Agency for Science, Technology and
      Research (A( *)STAR), Singapore 138667, Singapore; School of Laboratory Medicine
      and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
FAU - Lee, Dong-Sup
AU  - Lee DS
AD  - Department of Biomedical Sciences, Seoul National University College of Medicine,
      Seoul, Korea.
FAU - Kim, Young-Bum
AU  - Kim YB
AD  - Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School
      of Convergence Science and Technology, College of Medicine, Seoul National
      University, Seoul, Korea; Division of Endocrinology, Diabetes and Metabolism,
      Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical
      School, Boston, MA, USA.
FAU - Chung, Sung Soo
AU  - Chung SS
AD  - Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
      Electronic address: suschung@snu.ac.kr.
FAU - Park, Kyong Soo
AU  - Park KS
AD  - Genomic Medicine Institute, Medical Research Center, Seoul National University
      College of Medicine, Seoul, Korea; Department of Internal Medicine, Seoul
      National University College of Medicine, Seoul, Korea; Department of Molecular
      Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science
      and Technology, College of Medicine, Seoul National University, Seoul, Korea.
      Electronic address: kspark@snu.ac.kr.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Cell Rep
JT  - Cell reports
JID - 101573691
RN  - 0 (CCAAT-Enhancer-Binding Protein-beta)
RN  - 0 (Small Ubiquitin-Related Modifier Proteins)
RN  - EC 3.4.22.- (Cysteine Endopeptidases)
RN  - EC 3.4.22.68 (Senp2 protein, mouse)
SB  - IM
MH  - *Adipocytes, Beige/metabolism
MH  - Adipogenesis
MH  - Adipose Tissue, Brown/metabolism
MH  - Adipose Tissue, White/metabolism
MH  - Animals
MH  - *CCAAT-Enhancer-Binding Protein-beta/metabolism
MH  - *Cysteine Endopeptidases/metabolism
MH  - Energy Metabolism/physiology
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Knockout
MH  - *Small Ubiquitin-Related Modifier Proteins
MH  - Thermogenesis/genetics
OTO - NOTNLM
OT  - *C/EBPbeta
OT  - *HOXC10
OT  - *SENP2
OT  - *SUMO
OT  - *adipocytes
OT  - *adipogenesis
OT  - *browning
OT  - *obesity
OT  - *thermogenesis
OT  - *transcription
COIS- Declaration of interests The authors declare no competing interest.
EDAT- 2022/02/24 06:00
MHDA- 2022/03/17 06:00
CRDT- 2022/02/23 20:08
PHST- 2021/07/06 00:00 [received]
PHST- 2021/11/26 00:00 [revised]
PHST- 2022/01/27 00:00 [accepted]
PHST- 2022/02/23 20:08 [entrez]
PHST- 2022/02/24 06:00 [pubmed]
PHST- 2022/03/17 06:00 [medline]
AID - S2211-1247(22)00132-2 [pii]
AID - 10.1016/j.celrep.2022.110408 [doi]
PST - ppublish
SO  - Cell Rep. 2022 Feb 22;38(8):110408. doi: 10.1016/j.celrep.2022.110408.

PMID- 24792780
OWN - NLM
STAT- MEDLINE
DCOM- 20140806
LR  - 20140610
IS  - 1556-9519 (Electronic)
IS  - 1556-3650 (Linking)
VI  - 52
IP  - 5
DP  - 2014 Jun
TI  - Evaluation of dexmedetomidine therapy for sedation in patients with toxicological
      events at an academic medical center.
PG  - 525-30
LID - 10.3109/15563650.2014.913175 [doi]
AB  - INTRODUCTION: Although clinical use of dexmedetomidine (DEX), an
      alpha2-adrenergic receptor agonist, has increased, its role in patients admitted
      to intensive care units secondary to toxicological sequelae has not been well
      established. OBJECTIVES: The primary objective of this study was to describe
      clinical and adverse effects observed in poisoned patients receiving DEX for
      sedation. METHODS: This was an observational case series with retrospective chart
      review of poisoned patients who received DEX for sedation at an academic medical
      center. The primary endpoint was incidence of adverse effects of DEX therapy
      including bradycardia, hypotension, seizures, and arrhythmias. For comparison,
      vital signs were collected hourly for the 5 h preceding the DEX therapy and every
      hour during DEX therapy until the therapy ended. Additional endpoints included
      therapy duration; time within target Richmond Agitation Sedation Score (RASS);
      and concomitant sedation, analgesia, and vasopressor requirements. RESULTS:
      Twenty-two patients were included. Median initial and median DEX infusion rates
      were similar to the commonly used rates for sedation. Median heart rate was lower
      during the therapy (82 vs. 93 beats/minute, p < 0.05). Median systolic blood
      pressure before and during therapy was similar (111 vs. 109 mmHg, p = 0.745).
      Five patients experienced an adverse effect per study definitions during therapy.
      No additional adverse effects were noted. Median time within target RASS and
      duration of therapy was 6.5 and 44.5 h, respectively. Seventeen patients (77%)
      had concomitant use of other sedation and/or analgesia with four (23%) of these
      patients requiring additional agents after DEX initiation. Seven patients (32%)
      had concomitant vasopressor support with four (57%) of these patients requiring
      vasopressor support after DEX initiation. CONCLUSION: Common adverse effects of
      DEX were noted in this study. The requirement for vasopressor support during
      therapy warrants further investigation into the safety of DEX in poisoned
      patients. Larger, comparative studies need to be performed before the use of DEX
      can be routinely recommended in poisoned patients.
FAU - Mohorn, P L
AU  - Mohorn PL
AD  - Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of
      Pharmacy, University of South Carolina , Columbia, SC , USA.
FAU - Vakkalanka, J P
AU  - Vakkalanka JP
FAU - Rushton, W
AU  - Rushton W
FAU - Hardison, L
AU  - Hardison L
FAU - Woloszyn, A
AU  - Woloszyn A
FAU - Holstege, C
AU  - Holstege C
FAU - Corbett, S M
AU  - Corbett SM
LA  - eng
PT  - Journal Article
DEP - 20140505
PL  - England
TA  - Clin Toxicol (Phila)
JT  - Clinical toxicology (Philadelphia, Pa.)
JID - 101241654
RN  - 0 (Adrenergic alpha-2 Receptor Agonists)
RN  - 0 (Hypnotics and Sedatives)
RN  - 67VB76HONO (Dexmedetomidine)
SB  - IM
MH  - Academic Medical Centers
MH  - Adolescent
MH  - Adrenergic alpha-2 Receptor Agonists/adverse effects/*therapeutic use
MH  - Adult
MH  - Blood Pressure
MH  - Dexmedetomidine/adverse effects/*therapeutic use
MH  - Female
MH  - Heart Rate
MH  - Humans
MH  - Hypnotics and Sedatives/adverse effects/*therapeutic use
MH  - *Intensive Care Units
MH  - Male
MH  - Middle Aged
MH  - Poisoning/*therapy
MH  - Retrospective Studies
MH  - Time Factors
MH  - Young Adult
OTO - NOTNLM
OT  - Adverse effects
OT  - Alpha2-adrenergic receptor agonist
OT  - Overdose
OT  - Safety
EDAT- 2014/05/06 06:00
MHDA- 2014/08/07 06:00
CRDT- 2014/05/06 06:00
PHST- 2014/05/06 06:00 [entrez]
PHST- 2014/05/06 06:00 [pubmed]
PHST- 2014/08/07 06:00 [medline]
AID - 10.3109/15563650.2014.913175 [doi]
PST - ppublish
SO  - Clin Toxicol (Phila). 2014 Jun;52(5):525-30. doi: 10.3109/15563650.2014.913175.
      Epub 2014 May 5.

PMID- 30158200
OWN - NLM
STAT- MEDLINE
DCOM- 20190314
LR  - 20220310
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 362
DP  - 2018 Aug 29
TI  - Assessment of the genetic and clinical determinants of fracture risk: genome wide
      association and mendelian randomisation study.
PG  - k3225
LID - 10.1136/bmj.k3225 [doi]
AB  - OBJECTIVES: To identify the genetic determinants of fracture risk and assess the
      role of 15 clinical risk factors on osteoporotic fracture risk. DESIGN:
      Meta-analysis of genome wide association studies (GWAS) and a two-sample
      mendelian randomisation approach. SETTING: 25 cohorts from Europe, United States,
      east Asia, and Australia with genome wide genotyping and fracture data.
      PARTICIPANTS: A discovery set of 37 857 fracture cases and 227 116 controls; with
      replication in up to 147 200 fracture cases and 150 085 controls. Fracture cases
      were defined as individuals (>18 years old) who had fractures at any skeletal
      site confirmed by medical, radiological, or questionnaire reports. Instrumental
      variable analyses were performed to estimate effects of 15 selected clinical risk
      factors for fracture in a two-sample mendelian randomisation framework, using the
      largest previously published GWAS meta-analysis of each risk factor. RESULTS: Of
      15 fracture associated loci identified, all were also associated with bone
      mineral density and mapped to genes clustering in pathways known to be critical
      to bone biology (eg, SOST, WNT16, and ESR1) or novel pathways (FAM210A, GRB10,
      and ETS2). Mendelian randomisation analyses showed a clear effect of bone mineral
      density on fracture risk. One standard deviation decrease in genetically
      determined bone mineral density of the femoral neck was associated with a 55%
      increase in fracture risk (odds ratio 1.55 (95% confidence interval 1.48 to 1.63;
      P=1.5x10(-68)). Hand grip strength was inversely associated with fracture risk,
      but this result was not significant after multiple testing correction. The
      remaining clinical risk factors (including vitamin D levels) showed no evidence
      for an effect on fracture. CONCLUSIONS: This large scale GWAS meta-analysis for
      fracture identified 15 genetic determinants of fracture, all of which also
      influenced bone mineral density. Among the clinical risk factors for fracture
      assessed, only bone mineral density showed a major causal effect on fracture.
      Genetic predisposition to lower levels of vitamin D and estimated calcium intake
      from dairy sources were not associated with fracture risk.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not
      already granted under a licence) please go to
      http://group.bmj.com/group/rights-licensing/permissions.
FAU - Trajanoska, Katerina
AU  - Trajanoska K
AD  - Department of Internal Medicine, Erasmus MC, University Medical Center,
      Rotterdam, Netherlands.
AD  - Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam,
      Netherlands.
FAU - Morris, John A
AU  - Morris JA
AD  - Lady Davis Institute, Jewish General Hospital, McGill University, Montreal,
      Quebec, Canada.
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
FAU - Oei, Ling
AU  - Oei L
AD  - Department of Internal Medicine, Erasmus MC, University Medical Center,
      Rotterdam, Netherlands.
AD  - Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam,
      Netherlands.
FAU - Zheng, Hou-Feng
AU  - Zheng HF
AD  - DaP Lab, School of Life Sciences, Westlake University and Westlake Institute for
      Advanced Study, Hangzhou, Zhejiang, China.
AD  - Institute of Aging Research and the Affiliated Hospital, School of Medicine,
      Hangzhou Normal University, Hangzhou, Zhejiang, China.
FAU - Evans, David M
AU  - Evans DM
AD  - Medical Research Council Integrative Epidemiology Unit, University of Bristol,
      Bristol, UK.
AD  - University of Queensland Diamantina Institute, University of Queensland,
      Translational Research Institute, Brisbane, Australia.
FAU - Kiel, Douglas P
AU  - Kiel DP
AD  - Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston,
      MA, USA.
AD  - Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical
      School, Boston, MA, USA.
FAU - Ohlsson, Claes
AU  - Ohlsson C
AD  - Centre for Bone and Arthritis Research, Department of Internal Medicine,
      Institute of Medicine, Sahlgrenska, Gothenburg, Sweden.
FAU - Richards, J Brent
AU  - Richards JB
AD  - Lady Davis Institute, Jewish General Hospital, McGill University, Montreal,
      Quebec, Canada f.rivadeneira@erasmusmc.nl brent.richards@mcgill.ca.
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
FAU - Rivadeneira, Fernando
AU  - Rivadeneira F
AD  - Department of Internal Medicine, Erasmus MC, University Medical Center,
      Rotterdam, Netherlands f.rivadeneira@erasmusmc.nl brent.richards@mcgill.ca.
AD  - Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam,
      Netherlands.
CN  - GEFOS/GENOMOS consortium and the 23andMe research team
LA  - eng
GR  - UL1 RR024140/RR/NCRR NIH HHS/United States
GR  - U01 AR045580/AR/NIAMS NIH HHS/United States
GR  - R01 AR035582/AR/NIAMS NIH HHS/United States
GR  - 14136/CRUK_/Cancer Research UK/United Kingdom
GR  - R01 AG005394/AG/NIA NIH HHS/United States
GR  - MC_UU_12013/4/MRC_/Medical Research Council/United Kingdom
GR  - N01HC85081/HL/NHLBI NIH HHS/United States
GR  - UL1 TR001881/TR/NCATS NIH HHS/United States
GR  - R01 AG027574/AG/NIA NIH HHS/United States
GR  - U01 AR045614/AR/NIAMS NIH HHS/United States
GR  - R01 AR050066/AR/NIAMS NIH HHS/United States
GR  - T32 AG000186/AG/NIA NIH HHS/United States
GR  - N01HC85080/HL/NHLBI NIH HHS/United States
GR  - U01 AR045583/AR/NIAMS NIH HHS/United States
GR  - UL1 TR000124/TR/NCATS NIH HHS/United States
GR  - N01 AG062103/AG/NIA NIH HHS/United States
GR  - P01 AG005842/AG/NIA NIH HHS/United States
GR  - R01 AR035583/AR/NIAMS NIH HHS/United States
GR  - R01 AG023629/AG/NIA NIH HHS/United States
GR  - G9800062/MRC_/Medical Research Council/United Kingdom
GR  - U01 HL080295/HL/NHLBI NIH HHS/United States
GR  - N01 HC085079/HC/NHLBI NIH HHS/United States
GR  - R01 HL120393/HL/NHLBI NIH HHS/United States
GR  - P30 AG012810/AG/NIA NIH HHS/United States
GR  - U01 HL130114/HL/NHLBI NIH HHS/United States
GR  - R01 HL103612/HL/NHLBI NIH HHS/United States
GR  - N01 AG062106/AG/NIA NIH HHS/United States
GR  - 110141/Z/15/Z/WT_/Wellcome Trust/United Kingdom
GR  - MC_U147585819/MRC_/Medical Research Council/United Kingdom
GR  - U01 AG018197/AG/NIA NIH HHS/United States
GR  - MR/N003284/1/MRC_/Medical Research Council/United Kingdom
GR  - MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG027576/AG/NIA NIH HHS/United States
GR  - R01 AR072199/AR/NIAMS NIH HHS/United States
GR  - N01HC85082/HL/NHLBI NIH HHS/United States
GR  - R01 AR041398/AR/NIAMS NIH HHS/United States
GR  - U01 AR045647/AR/NIAMS NIH HHS/United States
GR  - U01 AR045632/AR/NIAMS NIH HHS/United States
GR  - R01 HL105756/HL/NHLBI NIH HHS/United States
GR  - MR/M004422/1/MRC_/Medical Research Council/United Kingdom
GR  - MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom
GR  - N01AG12100/AG/NIA NIH HHS/United States
GR  - R01 AR035584/AR/NIAMS NIH HHS/United States
GR  - N01HC55222/HL/NHLBI NIH HHS/United States
GR  - P30 DK063491/DK/NIDDK NIH HHS/United States
GR  - R01 AG032098/AG/NIA NIH HHS/United States
GR  - U01 AR045654/AR/NIAMS NIH HHS/United States
GR  - N01HC85083/HL/NHLBI NIH HHS/United States
GR  - G0401527/MRC_/Medical Research Council/United Kingdom
GR  - R01 AG026720/AG/NIA NIH HHS/United States
GR  - N01HC85086/HL/NHLBI NIH HHS/United States
GR  - N01 AG062101/AG/NIA NIH HHS/United States
GR  - G1000143/MRC_/Medical Research Council/United Kingdom
GR  - U01 AG027810/AG/NIA NIH HHS/United States
GR  - R01 AG005407/AG/NIA NIH HHS/United States
GR  - R01 HL087652/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20180829
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Bone Density/*genetics
MH  - Fractures, Bone/epidemiology/*genetics/physiopathology/prevention & control
MH  - Genetic Predisposition to Disease/epidemiology
MH  - *Genome-Wide Association Study
MH  - Humans
MH  - *Mendelian Randomization Analysis
MH  - Middle Aged
MH  - Multicenter Studies as Topic
MH  - Osteoporosis/epidemiology/*genetics/physiopathology
MH  - Risk Factors
MH  - Young Adult
PMC - PMC6113773
COIS- Competing interests: All authors have completed the ICMJE uniform disclosure form
      at www.icmje.org/coi_disclosure.pdf and declare: support from the organisations
      listed in the funding statement for the submitted work; BMP serves on the data
      safety monitoring board of a clinical trial funded by the manufacturer (Zoll
      LifeCor) and on the Steering Committee of the Yale Open Data Access Project
      funded by Johnson and Johnson; CEE is currently employed by AstraZeneca; SR has
      received grants from Eli Lilly, Amgen, UCB, and Ultragenyx, and has provided
      consultation for Novartis; KE is currently employed by Biogen; US, UT, GT, and
      KSt are employed by deCODE genetics/Amgen; and AK, JYT, and DAH are employed by
      23andMe, and hold stock or stock options in 23andMe.
IR  - Forgett V
FIR - Forgett, Vincenzo
IR  - Leong A
FIR - Leong, Aaron
IR  - Ahmad OS
FIR - Ahmad, Omar S
IR  - Laurin C
FIR - Laurin, Charles
IR  - Mokry LE
FIR - Mokry, Lauren E
IR  - Ross S
FIR - Ross, Stephanie
IR  - Elks CE
FIR - Elks, Cathy E
IR  - Bowden J
FIR - Bowden, Jack
IR  - Warrington NM
FIR - Warrington, Nicole M
IR  - Kleinman A
FIR - Kleinman, Aaron
IR  - Willems SM
FIR - Willems, Sara M
IR  - Wright D
FIR - Wright, Daniel
IR  - Day FR
FIR - Day, Felix R
IR  - Murray A
FIR - Murray, Anna
IR  - Ruth KS
FIR - Ruth, Katherine S
IR  - Tsilidis KK
FIR - Tsilidis, Konstantinos K
IR  - Ackert-Bicknell CL
FIR - Ackert-Bicknell, Cheryl L
IR  - Bassett JHD
FIR - Bassett, J H Duncan
IR  - van der Eerden BCJ
FIR - van der Eerden, Bram C J
IR  - Gautvik K
FIR - Gautvik, Kaare M
IR  - Reppe S
FIR - Reppe, Sjur
IR  - Williams GR
FIR - Williams, Graham R
IR  - Medina-Gomez C
FIR - Medina-Gomez, Carolina
IR  - Estrada K
FIR - Estrada, Karol
IR  - Amin N
FIR - Amin, Najaf
IR  - Bis JC
FIR - Bis, Joshua C
IR  - Breda S
FIR - Breda, Stephan
IR  - Chasman DI
FIR - Chasman, Daniel I
IR  - Demissie S
FIR - Demissie, Serkalem
IR  - Enneman AW
FIR - Enneman, Anke W
IR  - Hsu YH
FIR - Hsu, Yi-Hsiang
IR  - Ingvarsson T
FIR - Ingvarsson, Thorvaldur
IR  - Kahonen M
FIR - Kahonen, Mika
IR  - Kammerer C
FIR - Kammerer, Candace
IR  - Lacroix AZ
FIR - Lacroix, Andrea Z
IR  - Li G
FIR - Li, Guo
IR  - Liu CT
FIR - Liu, Ching-Ti
IR  - Liu Y
FIR - Liu, Yongmei
IR  - Lorentzon M
FIR - Lorentzon, Mattias
IR  - Magi R
FIR - Magi, Reedik
IR  - Mihailov E
FIR - Mihailov, Evelin
IR  - Mlani L
FIR - Mlani, Lili
IR  - Moayyeri A
FIR - Moayyeri, Alireza
IR  - Nielson CM
FIR - Nielson, Carrie M
IR  - Nerea A
FIR - Nerea, Alonso
IR  - Sham PC
FIR - Sham, Pack Chung
IR  - Siggeirsdotir K
FIR - Siggeirsdotir, Kristin
IR  - Sigurdsson G
FIR - Sigurdsson, Gunnar
IR  - Thorsteinsdottir U
FIR - Thorsteinsdottir, Unnur
IR  - Trompet S
FIR - Trompet, Stella
IR  - Thorleifsson G
FIR - Thorleifsson, Gudmar
IR  - Vandenput L
FIR - Vandenput, Liesbeth
IR  - van der Velde N
FIR - van der Velde, Nathalie
IR  - Viikari J
FIR - Viikari, Jorma
IR  - Xiao SM
FIR - Xiao, Su-Mei
IR  - Hua Zhao J
FIR - Hua Zhao, Jing
IR  - Akesson KE
FIR - Akesson, Kristina E
IR  - Andersen M
FIR - Andersen, Marianne
IR  - Atanasovska B
FIR - Atanasovska, Biljana
IR  - Balcells S
FIR - Balcells, Susana
IR  - Eriksson J
FIR - Eriksson, Joel
IR  - Formosa MM
FIR - Formosa, Melissa M
IR  - Garcia-Ibarbia C
FIR - Garcia-Ibarbia, Carmen
IR  - Gonzalez-Macias J
FIR - Gonzalez-Macias, Jesus
IR  - Garcia-Giralt N
FIR - Garcia-Giralt, Natalia
IR  - Hallmans G
FIR - Hallmans, Goran
IR  - Karlsson M
FIR - Karlsson, Magnus
IR  - Khusainova R
FIR - Khusainova, Rita
IR  - Kim BJ
FIR - Kim, Beom-Jun
IR  - Lee SH
FIR - Lee, Seung Hun
IR  - Leung PC
FIR - Leung, Ping C
IR  - Mallmin H
FIR - Mallmin, Hans
IR  - Kwok TCY
FIR - Kwok, Timothy C Y
IR  - Masi L
FIR - Masi, Laura
IR  - Melin BS
FIR - Melin, Beatrice S
IR  - Mencej-Bedrac S
FIR - Mencej-Bedrac, Simona
IR  - Nethander M
FIR - Nethander, Maria
IR  - Olmos JM
FIR - Olmos, Jose M
IR  - Kollia P
FIR - Kollia, Panagoula
IR  - Prezelj J
FIR - Prezelj, Janez
IR  - Van Schoor NM
FIR - Van Schoor, Natasja M
IR  - Svensson O
FIR - Svensson, Olle
IR  - Szulc P
FIR - Szulc, Pawel
IR  - Valero C
FIR - Valero, Carmen
IR  - Woo J
FIR - Woo, Jean
IR  - Brandi M
FIR - Brandi, Maria
IR  - Cheng S
FIR - Cheng, Sulin
IR  - Chapurlat R
FIR - Chapurlat, Roland
IR  - Christiansen C
FIR - Christiansen, Claus
IR  - Cooper C
FIR - Cooper, Cyrus
IR  - Dedoussis G
FIR - Dedoussis, George
IR  - Eisman JA
FIR - Eisman, John A
IR  - Frost M
FIR - Frost, Morten
IR  - Giroux S
FIR - Giroux, Sylvie
IR  - Grinberg D
FIR - Grinberg, Daniel
IR  - Goltzman D
FIR - Goltzman, David
IR  - Hocking LJ
FIR - Hocking, Lynne J
IR  - Van Hul W
FIR - Van Hul, Wim
IR  - Koh JM
FIR - Koh, Jung-Min
IR  - Rejnmark L
FIR - Rejnmark, Lars
IR  - Jensen JB
FIR - Jensen, Jens-Erik B
IR  - Langdahl B
FIR - Langdahl, Bente
IR  - Lewis JR
FIR - Lewis, Joshua R
IR  - Lorenc RS
FIR - Lorenc, Roman S
IR  - Khusnutdinova E
FIR - Khusnutdinova, Elza
IR  - Marc J
FIR - Marc, Janja
IR  - McGuigan FE
FIR - McGuigan, Fiona E
IR  - Mellstrom D
FIR - Mellstrom, Dan
IR  - Michaelsson K
FIR - Michaelsson, Karl
IR  - Nogues X
FIR - Nogues, Xavier
IR  - Nordstrom P
FIR - Nordstrom, Peter
IR  - Obermayer-Pietsch B
FIR - Obermayer-Pietsch, Barbara
IR  - Pettersson-Kymmer U
FIR - Pettersson-Kymmer, Ulrika
IR  - Prince RL
FIR - Prince, Richard L
IR  - Reeve J
FIR - Reeve, Jonathan
IR  - Reid DM
FIR - Reid, David M
IR  - Riancho JA
FIR - Riancho, Jose A
IR  - Rousseau F
FIR - Rousseau, Francois
IR  - Tang NLS
FIR - Tang, Nelson L S
IR  - Xuereb-Anastasi A
FIR - Xuereb-Anastasi, Angela
IR  - Leslie WD
FIR - Leslie, William D
IR  - Evans DS
FIR - Evans, Daniel S
IR  - Cummings SR
FIR - Cummings, Steven R
IR  - Cauley J
FIR - Cauley, Jane
IR  - van Duijn CM
FIR - van Duijn, Cornelia M
IR  - Brown M
FIR - Brown, Matt
IR  - Duncan EL
FIR - Duncan, Emma L
IR  - de Groot LC
FIR - de Groot, Lisette CPGM
IR  - Esko T
FIR - Esko, Tonu
IR  - Gudnason V
FIR - Gudnason, Vilmundar
IR  - Harris TB
FIR - Harris, Tamara B
IR  - Jackson RD
FIR - Jackson, Rebecca D
IR  - Jukema JW
FIR - Jukema, J Wouter
IR  - Ikram MA
FIR - Ikram, M Arfan
IR  - Karasik D
FIR - Karasik, David
IR  - Kaptoge S
FIR - Kaptoge, Stephen
IR  - Khaw KT
FIR - Khaw, Kay-Tee
IR  - Kung AW
FIR - Kung, Annie Wai-Chee
IR  - Lehtimaki T
FIR - Lehtimaki, Terho
IR  - Lyytikainen LP
FIR - Lyytikainen, Leo-Pekka
IR  - Lips P
FIR - Lips, Paul
IR  - Luben R
FIR - Luben, Robert
IR  - Metspalu A
FIR - Metspalu, Andres
IR  - van Meurs JBJ
FIR - van Meurs, Joyce B J
IR  - Minster RL
FIR - Minster, Ryan L
IR  - Orwoll E
FIR - Orwoll, Eric
IR  - Oei E
FIR - Oei, Edwin
IR  - Psaty BM
FIR - Psaty, Bruce M
IR  - Raitakari OT
FIR - Raitakari, Olli T
IR  - Ralston SH
FIR - Ralston, Stuart H
IR  - Ridker PM
FIR - Ridker, Paul M
IR  - Robbins JA
FIR - Robbins, John A
IR  - Smith AV
FIR - Smith, Albert V
IR  - Spector TD
FIR - Spector, Tim D
IR  - Styrkarsdottir U
FIR - Styrkarsdottir, Unnur
IR  - Zmuda J
FIR - Zmuda, Joseph
IR  - Tranah GJ
FIR - Tranah, Gregory J
IR  - Stefansson K
FIR - Stefansson, Kari
IR  - Uitterlinden AG
FIR - Uitterlinden, Andre G
IR  - Zillikens MC
FIR - Zillikens, M Carola
IR  - Ntzani EE
FIR - Ntzani, Evangelia E
IR  - Evangelou E
FIR - Evangelou, Evangelos
IR  - Ioannidis JPA
FIR - Ioannidis, John P A
IR  - Perry JRB
FIR - Perry, John R B
IR  - Tung JY
FIR - Tung, Joyce Y
IR  - Hinds DA
FIR - Hinds, David A
IR  - Scott R
FIR - Scott, Robert
IR  - Agee M
FIR - Agee, Michelle
IR  - Alipanahi B
FIR - Alipanahi, Babak
IR  - Auton A
FIR - Auton, Adam
IR  - Bell RK
FIR - Bell, Robert K
IR  - Bryc K
FIR - Bryc, Katarzyna
IR  - Elson SL
FIR - Elson, Sarah L
IR  - Fontanillas P
FIR - Fontanillas, Pierre
IR  - Furlotte NA
FIR - Furlotte, Nicholas A
IR  - Huber KE
FIR - Huber, Karen E
IR  - Litterman NK
FIR - Litterman, Nadia K
IR  - McIntyre MH
FIR - McIntyre, Matthew H
IR  - Mountain JL
FIR - Mountain, Joanna L
IR  - Noblin ES
FIR - Noblin, Elizabeth S
IR  - Northover CAM
FIR - Northover, Carrie A M
IR  - Pitts SJ
FIR - Pitts, Steven J
IR  - Sathirapongsasuti JF
FIR - Sathirapongsasuti, J Fah
IR  - Sazonova OV
FIR - Sazonova, Olga V
IR  - Shelton JF
FIR - Shelton, Janie F
IR  - Tian S
FIR - Tian, Suyash
IR  - Tian C
FIR - Tian, Chao
IR  - Vacic V
FIR - Vacic, Vladimir
IR  - Wilson. CH
FIR - Wilson., Catherine H
EDAT- 2018/08/31 06:00
MHDA- 2019/03/15 06:00
CRDT- 2018/08/31 06:00
PHST- 2018/08/31 06:00 [entrez]
PHST- 2018/08/31 06:00 [pubmed]
PHST- 2019/03/15 06:00 [medline]
AID - 10.1136/bmj.k3225 [doi]
PST - epublish
SO  - BMJ. 2018 Aug 29;362:k3225. doi: 10.1136/bmj.k3225.

PMID- 151222
OWN - NLM
STAT- MEDLINE
DCOM- 19781118
LR  - 20041117
IS  - 0377-5038 (Print)
IS  - 0377-5038 (Linking)
VI  - 24
IP  - 3
DP  - 1978 Jul-Sep
TI  - Histochemical and histoenzymic researches in coronary sudden death.
PG  - 229-32
AB  - Using Lie's technique in order to evidence the fuchsinophilia of the early
      ischaemic zones and Falck-Hillarp's technique to appreciate the disappearance of
      the myocardial adrenergic network, the authors followed up the concordance
      between the precocity of the ischaemia and the frequency of the acidophilia.
      Studying 54 cases of coronary sudden death by using 100-300 slides in each case,
      the fuchsinophilic zones were evidenced in 46 per cent of the cases, aspects
      indicating the morphologic substrate of the sudden death with ectopic ventricular
      electrical activity centres. The results of fluorescence Falck-Hillarps's
      technique are the same as those obtained by light microscopy, which is to be
      preferred in routine practice. Farber-Louviere's microscopic histoenzymic method
      for succinate-dehydrogenase presents multiple advantages, so that it is
      preferable to Kollin-Neoral's macroscopic reaction.
FAU - Alexandru, E
AU  - Alexandru E
FAU - Dobrescu, G
AU  - Dobrescu G
LA  - eng
PT  - Journal Article
PL  - Romania
TA  - Morphol Embryol (Bucur)
JT  - Morphologie et embryologie
JID - 7512183
RN  - 0 (Catecholamines)
RN  - EC 1.3.99.1 (Succinate Dehydrogenase)
SB  - IM
MH  - Catecholamines/*metabolism
MH  - Coronary Disease/*metabolism/pathology
MH  - Death, Sudden/*etiology
MH  - Histocytochemistry
MH  - Humans
MH  - Myocardium/*metabolism/pathology
MH  - Succinate Dehydrogenase/*metabolism
EDAT- 1978/07/01 00:00
MHDA- 1978/07/01 00:01
CRDT- 1978/07/01 00:00
PHST- 1978/07/01 00:00 [pubmed]
PHST- 1978/07/01 00:01 [medline]
PHST- 1978/07/01 00:00 [entrez]
PST - ppublish
SO  - Morphol Embryol (Bucur). 1978 Jul-Sep;24(3):229-32.
